Appointment Compliance in Patients With Diabetic Macular Edema and Exudative Macular Degeneration
Overview
Authors
Affiliations
Background And Objective: The purpose of this study is to compare cancellation and no-show rates in patients with diabetic macular edema (DME) and exudative macular degeneration (wet AMD).
Patients And Methods: An anonymous survey was sent to 1,726 retina specialists inquiring as to the number of appointments their patients with DME and wet AMD attended, cancelled, or did not show up for in 2014 and 2015.
Results: Data were obtained on 109,599 appointments. Patients with DME in the U.S. had a 1.591-times increased odds of cancelling or no-showing to their appointments than patients with wet AMD (P < .0001). Patients with DME in Europe had a 1.918-times increased odds of cancelling or no showing to their appointments than patients with wet AMD (P < .0001).
Conclusion: Patients with DME in the U.S. and Europe cancelled and no-showed to their appointments significantly more often than patients with wet AMD. These findings can be taken into consideration when establishing treatment plans for patients with DME. [Ophthalmic Surg Lasers Imaging Retina. 2018;49:186-190.].
Chalasani M, Maatouk C, Markle J, Singh R, Talcott K J Vitreoretin Dis. 2024; :24741264241305123.
PMID: 39678936 PMC: 11645682. DOI: 10.1177/24741264241305123.
Nakao S, Kusuhara S, Murakami T Graefes Arch Clin Exp Ophthalmol. 2024; 262(12):3749-3759.
PMID: 38995350 PMC: 11608304. DOI: 10.1007/s00417-024-06558-y.
Rubsam A, Hossl L, Rau S, Boker A, Zeitz O, Joussen A J Clin Med. 2024; 13(6).
PMID: 38542043 PMC: 10970839. DOI: 10.3390/jcm13061819.
Sustained Disease Control in DME Patients upon Treatment Cessation with Brolucizumab.
Garweg J, Steinhauer S J Clin Med. 2024; 13(6).
PMID: 38541760 PMC: 10971211. DOI: 10.3390/jcm13061534.
Spinetta R, Petrillo F, Reibaldi M, Tortori A, Mazzoni M, Metrangolo C Pharmaceutics. 2023; 15(10).
PMID: 37896220 PMC: 10610055. DOI: 10.3390/pharmaceutics15102461.